Published • loading... • Updated
NHS England approves delayed-release treatment for rare kidney disease - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
NHS England approves delayed-release treatment for rare kidney disease - Pharmafile
NHS England has approved the routine commissioning of delayed-release mercaptamine bitartrate for eligible patients with nephropathic cystinosis, providing an additional treatment option for people living with the ultra-rare inherited disorder. The decision means eligible patients aged one year and older who meet the commissioning criteria can now access the twice-daily treatment through NHS England specialised […] The post NHS England approves …
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
